July 30, 2016 11:15 AM ET

Biotechnology

Company Overview of Inhibitex, Inc.

Key Executives for Inhibitex, Inc.

NameBoard RelationshipsTitleAge
Russell H. Plumb M.B.A.19 RelationshipsChief Executive Officer, Chief Financial Officer and Principal Accounting Officer57
Demetrios Kydonieus 7 RelationshipsPresident and Director--
Joseph M. Patti M.S.P.H., Ph.D.9 RelationshipsFounder, Chief Scientific Officer, Senior Vice President of Research & Development and Assistant Secretary52
Geoffrey W. Henson Ph.D.No RelationshipsSenior Vice President of Drug Development68
Seth Hetherington M.D.No RelationshipsChief Medical Officer and Vice President of Clinical Development64

Inhibitex, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Demetrios Kydonieus 7 RelationshipsInhibitex, Inc.--
Jeffrey Galik 18 RelationshipsZymoGenetics, Inc.--
Erik De Clercq M.D., Ph.D. 7 RelationshipsInhibitex, Inc.--
Robert T. Schooley M.D. 95 RelationshipsGilead Sciences Inc.--
Charles Flexner M.D. 7 RelationshipsInhibitex, Inc.--
View All Board Members

Inhibitex, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D., Ph.D.Erik De Clercq7 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$364.0K
364.0K
380.7K
Bonus$1.6M
1.6M
260.9K
Total Short Term Compensation$364.0K
364.0K
475.3K
Total Value of Options
34.0M
Compensation as of Fiscal Year
Inhibitex, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

TRACON Pharmaceuticals, Inc. Announces Resignation of Ronald Shazer as Chief Medical Officer, Effective August 5, 2016
July 29, 2016 8:02 PM ET
Editas Medicine, Inc. Names Akshay Vaishnaw to the Board of Directors
July 29, 2016 12:00 PM ET
Spring Bank Pharmaceuticals, Inc. Appoints Todd C. Brady to the Company's Board of Directors
July 28, 2016 8:05 PM ET
U.S. Stem Cell, Inc. Announces Resignation of Sam Ahn as Member of the Board of Directors
July 28, 2016 8:03 PM ET
Provista Diagnostics Appoints Judith K. Wolf as Chief Medical Officer
July 28, 2016 1:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Inhibitex, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.